
Cortechs.ai provides AI-powered quantitative imaging tools that help clinicians diagnose and monitor neurological and oncological diseases. The company sells NeuroQuant® and related software as FDA…

Cortechs.ai provides AI-powered quantitative imaging tools that help clinicians diagnose and monitor neurological and oncological diseases. The company sells NeuroQuant® and related software as FDA…
Sector: Medical imaging AI for neurology and oncology
Flagship product: NeuroQuant family (FDA 510(k)-cleared, CE-marked)
Commercial reach: Deployed at >1,400 institutions in 44 countries; 2,000,000+ brains processed
Founded: Origins 1996; incorporated/NeuroQuant released 2002
Recent financing: Closed oversubscribed Series C (lead: Vilas Ventures)
Clinical and research-grade automated analysis of medical imaging to quantify brain atrophy, tumors, MS lesions and related biomarkers.
2001
Medical Equipment Manufacturing
Described as an oversubscribed Series C; some public profiles list the round with undisclosed totals.
“Genting Berhad (via Dragasac Limited) and Vilas Ventures are investors; others reported include National Institutes of Health and Vilas Ventures participation”
| Company |
|---|
Cortechs.ai is actively recruiting for a Business Development Manager for the Mid East territory - Michigan, Ohio, Indiana & Western Pennsylvania. We are looking for someone that is located in one of those states.
Responsibilities:
Required Experience:
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,500+
New This Week